Deerfield Management Company, L.P. (Series C) Cor Medix Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $5.37 Billion
- Q3 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Cor Medix Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 3,323,833 shares of CRMD stock, worth $37.7 Million. This represents 0.74% of its overall portfolio holdings.
Number of Shares
3,323,833Holding current value
$37.7 Million% of portfolio
0.74%Shares
1 transactions
Others Institutions Holding CRMD
# of Institutions
204Shares Held
41.2MCall Options Held
1.33MPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA3.98MShares$45.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$40.3 Million0.0% of portfolio
-
Marshall Wace, LLP London, X03.47MShares$39.4 Million0.05% of portfolio
-
State Street Corp Boston, MA1.84MShares$20.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.81MShares$20.5 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $467M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...